Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
about
Vaccinology in the third millennium: scientific and social challengesMicrobiology laboratory and the management of mother-child varicella-zoster virus infectionVaricella zoster vaccines and their implications for development of HSV vaccinesEvaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workersImpact of varicella vaccine on varicella-zoster virus dynamicsVaricella and varicella vaccination in South KoreaPrimary versus secondary failure after varicella vaccination: implications for interval between 2 dosesDeterminants of varicella breakthrough: results of a 2012 case control study.Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Effectiveness of 2 doses of varicella vaccine in children.Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responsesHow to design effective vaccines: lessons from an old success storySafety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.Failure of a Single Varicella Vaccination to Protect Children With Cancer From Life-Threatening Breakthrough Varicella.Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRCSerological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent AssaySeroepidemiology of varicella-zoster virus in Korea.Healthcare workers' knowledge and practices regarding expanded program on immunization in Kalasin, ThailandVaricella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence.Vaccines: correlates of vaccine-induced immunity.Pathogenesis and current approaches to control of varicella-zoster virus infections.Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination.Varicella: efficacy of two-dose vaccination in childhood.Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain.Vaccination against varicella: what's the point?Correlates of protection induced by vaccination.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.Perspectives on vaccines against varicella-zoster virus infections.The impact of vaccine success and awareness on epidemic dynamics.A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay.The impact of vaccine failure rate on epidemic dynamics in responsive networks.Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella.Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus.Varicella Virus Vaccination in the United States.
P2860
Q24261399-8AB031AE-239B-45E0-AA59-3F6D26AD8FB4Q26738745-A2293D12-76C5-4EEF-83D7-69013B05BA38Q28280820-76721649-C374-489B-9BF8-AA6998B46B74Q33562829-C53268E2-BD49-4593-88EE-AD72F3660C41Q33591264-B89DA1EE-7987-4EFE-89F9-9EF6BAAB7640Q33601820-7B703AE8-BBCD-4CDE-B31A-6E786FE574C1Q33880341-4AFA2AB6-1940-4546-A820-3AABF5BDB9C7Q34033922-6D332E2E-3895-444C-9348-DC85956B49DEQ34260743-F7BC5D2B-A816-423A-82BF-31B830F00A13Q34683751-734B15A2-2501-41F9-9751-58C2C9814813Q34763888-366EB7C6-7DF5-494F-B856-817D08238289Q35105463-C93244FD-F0F1-4628-997C-EBB97D8814FEQ35118610-9768F78C-9BD5-4967-A3CD-04A0E1B0552BQ35887597-937502EB-5444-4D11-A7E3-42744C0100E4Q35939962-25468332-C504-489D-9D0B-321E01016500Q36270547-7F7B7F69-8DFB-47FD-92AA-0D7C1D4DB42AQ36555118-7389655F-13F6-42C0-86CE-ED5A5827CDF2Q36589458-79274AA7-7196-43D5-B0BA-1BEFD3A65BEFQ36797066-08805D44-D792-4EAC-B9D4-72C9EAA5292AQ37011005-8A0624E0-98FB-4FE0-BFFB-09DBAE43E1CBQ37193062-1D53B241-93B6-4490-8016-59E7AB4E5AB8Q37263293-1409D7A9-CE52-4225-A2B2-016C2FBC2ED8Q37265904-AB812CD4-B025-493B-8469-9871B84BFB09Q37496720-B877A25C-1B69-4E76-AFD4-B5CED27BD717Q37505437-9B4FF5F3-6277-4AB3-A3D8-530CA14C792FQ37703012-10A36CE0-ED56-4176-AB3F-79E3BA15D2ECQ37750121-798B0DF9-2C58-4804-BCD4-4029A695B137Q38241377-8A94DF9D-A51C-4293-91FD-C97B3D04AEC9Q38667215-730C31CC-0508-4914-A2C3-7F4535189236Q39128973-3BE1C084-0E05-4D6E-BA47-CBE6606004E6Q40363716-BC4CD06E-1D17-44F8-93AF-E6DCB4216FFFQ40427373-1BECBD97-BA9E-4BBA-9FA9-75EA8B89BAF3Q40499818-11C3884D-398C-435E-98FC-147A43A24421Q40540257-84B63D47-2F0A-4D23-B939-4727C3483E3DQ41266138-355DF98E-5C6F-4B7D-8A4E-5D3CFB9FCB7BQ41982145-AF546472-2C5D-48AE-A005-3ED3143231ABQ42202653-F0CF4408-3444-4709-8EB3-B841D76A4778Q42366475-97755C8B-E9DE-412F-BC18-F8D22F68229EQ42849184-4F722E76-E3F6-4855-82F1-7AF2EFE22377Q45324301-11E62879-7102-4824-A10D-00D5220BF735
P2860
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@en
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@nl
type
label
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@en
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@nl
prefLabel
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@en
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@nl
P2093
P2860
P356
P1476
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
@en
P2093
Ann M Arvin
Anne A Gershon
David E Michalik
Haley A Gans
Peter F Wright
Philip S Larussa
Sharon P Steinberg
P2860
P304
P356
10.1086/529043
P407
P577
2008-04-01T00:00:00Z